Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
CALL
Iris Energy
IREN
$14.2B
| $28.4M | 0.01% |
751,900
+302,200
| +67% | +$15.6M |
|
1052
Murphy Oil
MUR
$5.12B
| $28.2M | 0.01% |
903,570
-2,876
| -0.3% | -$86.5K |
|
1053
PUT
Hershey
HSY
$36.6B
| $28.2M | 0.01% |
155,000
| – | – |
|
1054
Conagra Brands
CAG
$7.14B
| $28.2M | 0.01% |
1,628,453
+64,828
| +4% | +$1.15M |
|
1055
Home BancShares
HOMB
$6.22B
| $28.1M | 0.01% |
1,011,942
-16,924
| -2% | -$469K |
|
1056
Veeva Systems
VEEV
$38.4B
| $28.1M | 0.01% |
125,919
+36,212
| +40% | +$9.61M |
|
1057
Canadian National Railway
CNI
$76.4B
| $28.1M | 0.01% |
284,145
+97,666
| +52% | +$9.39M |
|
1058
HEICO Corp
HEI
$51.3B
| $28M | 0.01% |
86,676
+6,221
| +8% | +$1.97M |
|
1059
CALL
Mercado Libre
MELI
$98.4B
| $28M | 0.01% |
13,900
+6,000
| +76% | +$12.6M |
|
1060
AeroVironment
AVAV
$9.92B
| $27.9M | 0.01% |
115,390
+11,916
| +12% | +$3.75M |
|
1061
PUT
Baidu
BIDU
$35.9B
| $27.9M | 0.01% |
213,200
+43,200
| +25% | +$5.36M |
|
1062
MP Materials
MP
$9.84B
| $27.8M | 0.01% |
550,673
+320,605
| +139% | +$20.3M |
|
1063
Cooper Companies
COO
$15B
| $27.8M | 0.01% |
339,054
-132,376
| -28% | -$9.91M |
|
1064
CALL
AstraZeneca
AZN
$246B
| $27.8M | 0.01% |
151,000
-166,500
| -52% | -$29.2M |
|
1065
PUT
United Rentals
URI
$71.2B
| $27.8M | 0.01% |
34,300
+2,300
| +7% | +$2M |
|
1066
Cipher Digital
CIFR
$7.14B
| $27.7M | 0.01% |
1,877,455
+1,491,252
| +386% | +$26.3M |
|
|
SGI
1067
Somnigroup International
SGI
$13.7B
| $27.6M | 0.01% |
308,918
-82,390
| -21% | -$7.2M |
|
1068
PUT
Occidental Petroleum
OXY
$59B
| $27.6M | 0.01% |
+670,000
| New | +$28M |
|
1069
PUT
Cinemark Holdings
CNK
$4.25B
| $27.4M | 0.01% |
+1,177,900
| New | +$31M |
|
1070
PUT
Northrop Grumman
NOC
$81.8B
| $27.4M | 0.01% |
+48,000
| New | +$27.9M |
|
1071
Universal Health Services
UHS
$9.94B
| $27.3M | 0.01% |
125,171
-18,597
| -13% | -$4.11M |
|
1072
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.73B
| $27.3M | 0.01% |
+419,700
| New | +$27.2M |
|
1073
Baxter International
BAX
$14.3B
| $27.3M | 0.01% |
1,426,510
-76,849
| -5% | -$1.54M |
|
1074
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $27.3M | 0.01% |
223,500
+91,000
| +69% | +$10.4M |
|
1075
State Street Financial Select Sector SPDR ETF
XLF
$59B
| $27.1M | 0.01% |
495,058
-1,516,550
| -75% | -$80.8M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.